晚期肾细胞癌中的酪氨酸激酶抑制剂：不断演变的治疗模式。 - Suppr

Tyrosine kinase inhibitors in advanced renal cell carcinoma: the evolving treatment paradigm.

作者信息

Bukowski Ronald M

出版信息

Clin Genitourin Cancer. 2009 Jan;7(1):9-10. doi: 10.3816/CGC.2009.n.001.

DOI:10.3816/CGC.2009.n.001

PMID:19213661

Abstract

摘要

相似文献

Tyrosine kinase inhibitors in advanced renal cell carcinoma: the evolving treatment paradigm.

Clin Genitourin Cancer. 2009 Jan;7(1):9-10. doi: 10.3816/CGC.2009.n.001.

Two new drugs for renal cell carcinoma.

Med Lett Drugs Ther. 2007 Feb 26;49(1255):18-20.

[Management of hypothyroidism secondary to tyrosine kinase inhibitors: description of treatment in three distinct clinical settings].

Endocrinol Nutr. 2011 Feb;58(2):94-6. doi: 10.1016/j.endonu.2010.09.012. Epub 2011 Feb 17.

[Medical treatment of metastatic renal cell carcinoma after the approval and market entry of multitargeted tyrosine kinase inhibitors in Germany].

Aktuelle Urol. 2009 Jan;40(1):31-6. doi: 10.1055/s-2008-1038176. Epub 2009 Jan 28.

[Role of VEGFR-TKIs in the treatment of renal cell carcinoma].

Nihon Jinzo Gakkai Shi. 2012;54(5):574-80.

Secondary erythrocytosis produced by the tyrosine kinase inhibitors sunitinib and sorafenib.

J Clin Oncol. 2008 Aug 20;26(24):4047-8. doi: 10.1200/JCO.2008.18.3525.

[Managing the side effects of angiogenetic inhibitors in metastatic renal cell carcinoma].

Urologe A. 2006 Oct;45(10):1333-42; quiz 1343. doi: 10.1007/s00120-006-1211-7.

Newly approved therapies for RCC and their effect on the standard of care.

Clin Adv Hematol Oncol. 2007 Jan;5(1):35-6, 66.

Frequent dose interruptions are required for patients receiving oral kinase inhibitor therapy for advanced renal cell carcinoma.

Am J Clin Oncol. 2010 Jun;33(3):217-20. doi: 10.1097/COC.0b013e3181a650a6.

Cutaneous toxicities of the multikinase inhibitors sorafenib and sunitinib.

Dermatol Ther. 2011 Jul-Aug;24(4):396-400. doi: 10.1111/j.1529-8019.2011.01435.x.

引用本文的文献

Third generation tyrosine kinase inhibitors and their development in advanced renal cell carcinoma.

Front Oncol. 2012 Feb 15;2:13. doi: 10.3389/fonc.2012.00013. eCollection 2012.

CpG array analysis of histone H3 lysine 4 trimethylation by chromatin immunoprecipitation linked to microarrays analysis in peripheral blood mononuclear cells of IgA nephropathy patients.

Yonsei Med J. 2012 Mar;53(2):377-85. doi: 10.3349/ymj.2012.53.2.377.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Tyrosine kinase inhibitors in advanced renal cell carcinoma: the evolving treatment paradigm.

作者信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

Tyrosine kinase inhibitors in advanced renal cell carcinoma: the evolving treatment paradigm.

作者信息

出版信息

相似文献

引用本文的文献